Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Exchange Rate Effect (2016 - 2018)

Altimmune (ALT) has disclosed Exchange Rate Effect for 9 consecutive years, with -$48470.0 as the latest value for Q2 2018.

  • On a quarterly basis, Exchange Rate Effect fell 209.77% to -$48470.0 in Q2 2018 year-over-year; TTM through Dec 2018 was -$50365.0, a 167.71% decrease, with the full-year FY2018 number at -$50365.0, down 167.71% from a year prior.
  • Exchange Rate Effect was -$48470.0 for Q2 2018 at Altimmune, down from -$1895.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $44154.0 in Q2 2017 to a low of -$98830.0 in Q2 2016.
  • A 5-year average of -$9007.7 and a median of -$1696.0 in 2016 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: skyrocketed 2436.12% in 2015, then crashed 13782.14% in 2016.
  • Altimmune's Exchange Rate Effect stood at -$5256.0 in 2014, then soared by 63.01% to -$1944.0 in 2015, then rose by 22.99% to -$1497.0 in 2016, then crashed by 734.47% to -$12492.0 in 2017, then crashed by 288.01% to -$48470.0 in 2018.
  • Per Business Quant, the three most recent readings for ALT's Exchange Rate Effect are -$48470.0 (Q2 2018), -$1895.0 (Q1 2018), and -$12492.0 (Q4 2017).